Congenital Hematological Disorder Completed Phase Trials for Turoctocog alfa (DB09109)
Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder
| Indication | Status | Phase |
|---|---|---|
| DBCOND0081791 (Congenital Hematological Disorder) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03179748 | Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients | ||
| NCT02207218 | To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan | ||
| NCT02035384 | Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A |